Innoviva

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.

About INVA

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI.

CEO

Pavel Raifeld

CEOPavel Raifeld

Employees

—

Employees—

Headquarters

Burlingame, California

HeadquartersBurlingame, California

Founded

1996

Founded1996

Employees

—

Employees—

INVA Key Statistics

Market cap

971.80M

Market cap971.80M

Price-Earnings ratio

7.04

Price-Earnings ratio7.04

Dividend yield

—

Dividend yield—

Average volume

692.88K

Average volume692.88K

High today

$15.37

High today$15.37

Low today

$15.09

Low today$15.09

Open price

$15.24

Open price$15.24

Volume

397.57K

Volume397.57K

52 Week high

$16.87

52 Week high$16.87

52 Week low

$11.40

52 Week low$11.40